| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Insulin-Secreting Cells | 40 | 2018 | 441 | 5.040 |
Why?
|
| Diabetes Mellitus, Type 2 | 38 | 2023 | 1229 | 4.680 |
Why?
|
| Islets of Langerhans | 43 | 2020 | 556 | 4.500 |
Why?
|
| Insulin | 61 | 2020 | 1184 | 4.410 |
Why?
|
| Diabetes Mellitus | 32 | 2024 | 762 | 3.700 |
Why?
|
| Glucose | 43 | 2022 | 686 | 3.170 |
Why?
|
| Diabetes Mellitus, Type 1 | 27 | 2026 | 590 | 3.000 |
Why?
|
| Potassium Channels | 30 | 2018 | 346 | 2.190 |
Why?
|
| Insulin Resistance | 10 | 2024 | 379 | 1.980 |
Why?
|
| Potassium Channels, Inwardly Rectifying | 19 | 2024 | 121 | 1.880 |
Why?
|
| Precision Medicine | 10 | 2024 | 457 | 1.880 |
Why?
|
| Calcium Signaling | 9 | 2013 | 138 | 1.710 |
Why?
|
| Calcium | 32 | 2018 | 1173 | 1.510 |
Why?
|
| Potassium Channels, Voltage-Gated | 8 | 2010 | 111 | 1.240 |
Why?
|
| Islets of Langerhans Transplantation | 11 | 2022 | 247 | 1.120 |
Why?
|
| Animals | 154 | 2021 | 27973 | 1.100 |
Why?
|
| Glucokinase | 7 | 2023 | 61 | 1.080 |
Why?
|
| Hypoglycemic Agents | 18 | 2023 | 378 | 1.040 |
Why?
|
| Models, Biological | 16 | 2013 | 1768 | 0.990 |
Why?
|
| Mice | 90 | 2021 | 12230 | 0.960 |
Why?
|
| Second Messenger Systems | 3 | 2016 | 39 | 0.920 |
Why?
|
| Adenoviridae | 32 | 2002 | 340 | 0.900 |
Why?
|
| Humans | 184 | 2026 | 93132 | 0.880 |
Why?
|
| Membrane Potentials | 23 | 2018 | 404 | 0.860 |
Why?
|
| Mutation | 30 | 2024 | 4265 | 0.860 |
Why?
|
| Glucagon-Secreting Cells | 4 | 2018 | 27 | 0.850 |
Why?
|
| Werner Syndrome | 1 | 2024 | 3 | 0.840 |
Why?
|
| Systems Biology | 2 | 2016 | 47 | 0.830 |
Why?
|
| Genetic Testing | 8 | 2022 | 564 | 0.790 |
Why?
|
| Blood Glucose | 19 | 2022 | 866 | 0.780 |
Why?
|
| Sleep Disorders, Intrinsic | 1 | 2023 | 5 | 0.780 |
Why?
|
| Sulfonylurea Compounds | 10 | 2024 | 71 | 0.720 |
Why?
|
| Registries | 6 | 2019 | 995 | 0.720 |
Why?
|
| Ion Channels | 5 | 2013 | 256 | 0.710 |
Why?
|
| Hepatocyte Nuclear Factor 1-alpha | 8 | 2023 | 80 | 0.710 |
Why?
|
| Chromosomes, Human, Pair 6 | 3 | 2024 | 127 | 0.670 |
Why?
|
| Secretory Vesicles | 3 | 2013 | 42 | 0.640 |
Why?
|
| Reactive Oxygen Species | 5 | 2007 | 502 | 0.630 |
Why?
|
| Glucagon-Like Peptide 1 | 6 | 2022 | 59 | 0.600 |
Why?
|
| Adenosine Triphosphate | 10 | 2024 | 312 | 0.600 |
Why?
|
| Hyperglycemia | 8 | 2020 | 178 | 0.600 |
Why?
|
| Sleep | 2 | 2023 | 448 | 0.590 |
Why?
|
| Shab Potassium Channels | 7 | 2009 | 20 | 0.590 |
Why?
|
| Mice, Inbred C57BL | 23 | 2020 | 3431 | 0.580 |
Why?
|
| Calcium Channels | 10 | 2012 | 180 | 0.560 |
Why?
|
| Computer Simulation | 7 | 2013 | 1120 | 0.550 |
Why?
|
| Adenoviruses, Human | 24 | 1984 | 41 | 0.550 |
Why?
|
| Developmental Disabilities | 4 | 2016 | 204 | 0.550 |
Why?
|
| RNA, Messenger | 45 | 2015 | 2020 | 0.550 |
Why?
|
| Infant, Newborn, Diseases | 7 | 2024 | 91 | 0.540 |
Why?
|
| Viral Proteins | 28 | 1988 | 247 | 0.530 |
Why?
|
| Infant, Newborn | 23 | 2024 | 2427 | 0.530 |
Why?
|
| Gene Expression Regulation | 21 | 2018 | 1980 | 0.520 |
Why?
|
| Potassium Channels, Calcium-Activated | 2 | 2010 | 20 | 0.520 |
Why?
|
| Glucagon | 5 | 2018 | 114 | 0.500 |
Why?
|
| ATP-Binding Cassette Transporters | 7 | 2011 | 140 | 0.490 |
Why?
|
| Microscopy, Confocal | 7 | 2021 | 281 | 0.490 |
Why?
|
| Proinsulin | 7 | 2013 | 123 | 0.480 |
Why?
|
| RNA, Viral | 31 | 1995 | 285 | 0.470 |
Why?
|
| Membrane Proteins | 13 | 2013 | 1260 | 0.470 |
Why?
|
| Diabetic Ketoacidosis | 1 | 2015 | 13 | 0.450 |
Why?
|
| Cyclic AMP | 3 | 2016 | 275 | 0.450 |
Why?
|
| Transcription, Genetic | 27 | 2018 | 1114 | 0.450 |
Why?
|
| Hypoglycemia | 4 | 2022 | 112 | 0.440 |
Why?
|
| Action Potentials | 2 | 2009 | 578 | 0.440 |
Why?
|
| Cell Division | 11 | 1998 | 689 | 0.430 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2016 | 163 | 0.430 |
Why?
|
| Receptors, Drug | 7 | 2011 | 51 | 0.420 |
Why?
|
| Cell Membrane | 11 | 2010 | 661 | 0.420 |
Why?
|
| Phenotype | 9 | 2021 | 2545 | 0.420 |
Why?
|
| DNA | 26 | 2006 | 1260 | 0.420 |
Why?
|
| Base Sequence | 54 | 2000 | 2207 | 0.420 |
Why?
|
| Cloning, Molecular | 29 | 2003 | 577 | 0.410 |
Why?
|
| DNA-Binding Proteins | 6 | 2010 | 1231 | 0.410 |
Why?
|
| Electrophysiological Phenomena | 2 | 2012 | 49 | 0.410 |
Why?
|
| Cyclic GMP | 2 | 2012 | 62 | 0.400 |
Why?
|
| Psychomotor Disorders | 1 | 2013 | 20 | 0.400 |
Why?
|
| Diagnostic Errors | 1 | 2014 | 156 | 0.400 |
Why?
|
| Male | 51 | 2024 | 44355 | 0.400 |
Why?
|
| Sulfonylurea Receptors | 10 | 2024 | 49 | 0.390 |
Why?
|
| Cell Line | 36 | 2013 | 2458 | 0.390 |
Why?
|
| Transcription Factors | 7 | 2018 | 1687 | 0.380 |
Why?
|
| Internet | 2 | 2015 | 345 | 0.380 |
Why?
|
| Secretory Pathway | 1 | 2013 | 23 | 0.380 |
Why?
|
| KATP Channels | 2 | 2010 | 18 | 0.370 |
Why?
|
| Luminescent Proteins | 4 | 2008 | 141 | 0.370 |
Why?
|
| Female | 50 | 2024 | 48542 | 0.370 |
Why?
|
| Repressor Proteins | 4 | 2006 | 443 | 0.360 |
Why?
|
| Mice, Knockout | 16 | 2017 | 2121 | 0.360 |
Why?
|
| Chromosome Aberrations | 1 | 2013 | 348 | 0.360 |
Why?
|
| Small Ubiquitin-Related Modifier Proteins | 1 | 2012 | 13 | 0.360 |
Why?
|
| In Vitro Techniques | 19 | 2021 | 944 | 0.360 |
Why?
|
| Child | 16 | 2024 | 7273 | 0.360 |
Why?
|
| Membrane Glycoproteins | 4 | 2008 | 443 | 0.350 |
Why?
|
| Molecular Sequence Data | 31 | 2010 | 2889 | 0.340 |
Why?
|
| Vascularized Composite Allotransplantation | 2 | 2021 | 17 | 0.340 |
Why?
|
| Cells, Cultured | 23 | 2018 | 2827 | 0.330 |
Why?
|
| Congenital Hyperinsulinism | 3 | 2024 | 15 | 0.330 |
Why?
|
| Oxidative Stress | 5 | 2007 | 467 | 0.330 |
Why?
|
| Organoids | 2 | 2021 | 76 | 0.330 |
Why?
|
| Cell Cycle | 5 | 2016 | 515 | 0.320 |
Why?
|
| Systems Analysis | 1 | 2010 | 16 | 0.320 |
Why?
|
| Adenosine Diphosphate | 2 | 2010 | 58 | 0.300 |
Why?
|
| Receptors, Virus | 5 | 2008 | 73 | 0.300 |
Why?
|
| Arachidonic Acid | 3 | 2007 | 62 | 0.300 |
Why?
|
| Fluorescence Resonance Energy Transfer | 2 | 2012 | 100 | 0.300 |
Why?
|
| Protein Precursors | 7 | 2007 | 133 | 0.300 |
Why?
|
| Forkhead Transcription Factors | 3 | 2017 | 174 | 0.300 |
Why?
|
| Insulinoma | 8 | 2007 | 38 | 0.290 |
Why?
|
| Recombinant Fusion Proteins | 5 | 2008 | 550 | 0.290 |
Why?
|
| Genes | 18 | 1994 | 256 | 0.290 |
Why?
|
| Inositol 1,4,5-Trisphosphate | 2 | 2005 | 27 | 0.280 |
Why?
|
| Spleen | 3 | 2006 | 372 | 0.280 |
Why?
|
| Exocytosis | 5 | 2015 | 108 | 0.280 |
Why?
|
| Enterovirus B, Human | 6 | 2008 | 9 | 0.280 |
Why?
|
| bcl-Associated Death Protein | 1 | 2008 | 18 | 0.270 |
Why?
|
| Amino Acid Sequence | 28 | 2010 | 1994 | 0.270 |
Why?
|
| Enkephalins | 2 | 2006 | 14 | 0.270 |
Why?
|
| DNA, Viral | 19 | 1983 | 234 | 0.270 |
Why?
|
| Pancreas | 3 | 2024 | 256 | 0.270 |
Why?
|
| Infant | 14 | 2024 | 3156 | 0.260 |
Why?
|
| Models, Neurological | 2 | 2009 | 408 | 0.260 |
Why?
|
| Adolescent | 15 | 2024 | 9550 | 0.260 |
Why?
|
| Mitochondria | 5 | 2015 | 612 | 0.250 |
Why?
|
| Gene Expression | 13 | 2007 | 1304 | 0.250 |
Why?
|
| Transient Receptor Potential Channels | 1 | 2007 | 5 | 0.250 |
Why?
|
| Ethics, Research | 1 | 2007 | 53 | 0.250 |
Why?
|
| Rats | 24 | 2006 | 4028 | 0.250 |
Why?
|
| Endoplasmic Reticulum | 6 | 2008 | 253 | 0.250 |
Why?
|
| Cold Climate | 1 | 2006 | 4 | 0.240 |
Why?
|
| Glucagon-Like Peptide-1 Receptor | 3 | 2022 | 30 | 0.240 |
Why?
|
| G1 Phase | 3 | 1995 | 64 | 0.240 |
Why?
|
| Kv Channel-Interacting Proteins | 1 | 2006 | 9 | 0.240 |
Why?
|
| Tetraethylammonium | 5 | 2009 | 23 | 0.240 |
Why?
|
| Freund's Adjuvant | 1 | 2006 | 25 | 0.240 |
Why?
|
| Cell Transplantation | 1 | 2006 | 46 | 0.240 |
Why?
|
| Apoptosis | 7 | 2015 | 1719 | 0.240 |
Why?
|
| C-Peptide | 3 | 2018 | 184 | 0.240 |
Why?
|
| Acclimatization | 1 | 2006 | 88 | 0.230 |
Why?
|
| Diabetes, Gestational | 2 | 2024 | 49 | 0.230 |
Why?
|
| Ribonucleosides | 2 | 2005 | 22 | 0.230 |
Why?
|
| Ion Channel Gating | 4 | 2005 | 302 | 0.230 |
Why?
|
| Patch-Clamp Techniques | 11 | 2021 | 378 | 0.230 |
Why?
|
| Transfection | 8 | 2012 | 877 | 0.230 |
Why?
|
| Adult | 26 | 2024 | 27849 | 0.230 |
Why?
|
| Cells | 1 | 2005 | 30 | 0.230 |
Why?
|
| Aminoimidazole Carboxamide | 1 | 2005 | 8 | 0.230 |
Why?
|
| Multienzyme Complexes | 1 | 2005 | 54 | 0.220 |
Why?
|
| Barbiturates | 1 | 2005 | 12 | 0.220 |
Why?
|
| Coumarins | 1 | 2005 | 13 | 0.220 |
Why?
|
| Ethanolamines | 1 | 2005 | 24 | 0.220 |
Why?
|
| Muscles | 3 | 1990 | 177 | 0.220 |
Why?
|
| Genes, Viral | 10 | 2001 | 101 | 0.220 |
Why?
|
| Isoxazoles | 1 | 2005 | 78 | 0.220 |
Why?
|
| Homeostasis | 6 | 2015 | 459 | 0.210 |
Why?
|
| Carrier Proteins | 4 | 2013 | 660 | 0.210 |
Why?
|
| Helix-Loop-Helix Motifs | 2 | 1994 | 27 | 0.210 |
Why?
|
| Werner Syndrome Helicase | 1 | 2024 | 3 | 0.210 |
Why?
|
| Mice, Transgenic | 10 | 2015 | 1581 | 0.210 |
Why?
|
| Patient-Centered Care | 3 | 2021 | 221 | 0.210 |
Why?
|
| Young Adult | 9 | 2021 | 6922 | 0.210 |
Why?
|
| Diabetes Mellitus, Experimental | 3 | 2015 | 201 | 0.210 |
Why?
|
| GTP-Binding Proteins | 4 | 2007 | 147 | 0.210 |
Why?
|
| Brain | 5 | 2021 | 2337 | 0.200 |
Why?
|
| Sodium Channels | 3 | 2007 | 130 | 0.200 |
Why?
|
| Delayed Rectifier Potassium Channels | 4 | 2009 | 13 | 0.200 |
Why?
|
| Glucose Intolerance | 4 | 2016 | 100 | 0.200 |
Why?
|
| Glucose Tolerance Test | 9 | 2018 | 233 | 0.200 |
Why?
|
| Quality of Life | 4 | 2020 | 1776 | 0.200 |
Why?
|
| Blood Glucose Self-Monitoring | 2 | 2022 | 62 | 0.200 |
Why?
|
| Middle Aged | 15 | 2024 | 27535 | 0.200 |
Why?
|
| Models, Theoretical | 3 | 2019 | 494 | 0.200 |
Why?
|
| Mental Health | 3 | 2020 | 187 | 0.190 |
Why?
|
| Endocrinology | 2 | 2020 | 50 | 0.190 |
Why?
|
| Superoxides | 1 | 2003 | 75 | 0.190 |
Why?
|
| Adrenergic beta-2 Receptor Agonists | 1 | 2002 | 27 | 0.190 |
Why?
|
| Adrenergic beta-Agonists | 1 | 2002 | 69 | 0.190 |
Why?
|
| Glyburide | 5 | 2024 | 33 | 0.190 |
Why?
|
| United States | 12 | 2022 | 7581 | 0.190 |
Why?
|
| Incretins | 3 | 2014 | 15 | 0.180 |
Why?
|
| Bacterial Proteins | 1 | 2008 | 878 | 0.180 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2026 | 2465 | 0.180 |
Why?
|
| Type C Phospholipases | 2 | 2016 | 26 | 0.180 |
Why?
|
| Research | 8 | 1992 | 250 | 0.180 |
Why?
|
| Cytoprotection | 2 | 2016 | 51 | 0.180 |
Why?
|
| DNA, Complementary | 7 | 2012 | 379 | 0.180 |
Why?
|
| Composite Tissue Allografts | 1 | 2021 | 10 | 0.180 |
Why?
|
| RNA | 18 | 1996 | 574 | 0.180 |
Why?
|
| Genetic Variation | 3 | 2018 | 1416 | 0.180 |
Why?
|
| Consensus | 2 | 2022 | 366 | 0.180 |
Why?
|
| Hyperinsulinism | 2 | 2019 | 44 | 0.170 |
Why?
|
| Ribonucleoproteins | 6 | 1988 | 36 | 0.170 |
Why?
|
| Receptors, Opioid, kappa | 2 | 2006 | 19 | 0.170 |
Why?
|
| Fasting | 3 | 2018 | 164 | 0.170 |
Why?
|
| Oocytes | 6 | 1996 | 211 | 0.170 |
Why?
|
| Metformin | 1 | 2022 | 126 | 0.170 |
Why?
|
| HeLa Cells | 31 | 1991 | 517 | 0.170 |
Why?
|
| Gene Transfer Techniques | 2 | 2001 | 154 | 0.170 |
Why?
|
| Green Fluorescent Proteins | 5 | 2006 | 309 | 0.170 |
Why?
|
| Finite Element Analysis | 1 | 2021 | 75 | 0.170 |
Why?
|
| Transforming Growth Factor beta | 2 | 1995 | 346 | 0.170 |
Why?
|
| Chloride Channels | 2 | 2012 | 43 | 0.170 |
Why?
|
| Cytoplasm | 7 | 2008 | 275 | 0.160 |
Why?
|
| Baculoviridae | 1 | 2000 | 33 | 0.160 |
Why?
|
| Information Systems | 3 | 1989 | 29 | 0.160 |
Why?
|
| S Phase | 3 | 1995 | 64 | 0.160 |
Why?
|
| Regeneration | 2 | 2016 | 159 | 0.160 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2007 | 940 | 0.160 |
Why?
|
| 3T3 Cells | 11 | 2000 | 94 | 0.160 |
Why?
|
| Kidney | 6 | 2002 | 1093 | 0.160 |
Why?
|
| Protein Biosynthesis | 19 | 2014 | 372 | 0.160 |
Why?
|
| Cost-Benefit Analysis | 4 | 2022 | 494 | 0.160 |
Why?
|
| Promoter Regions, Genetic | 6 | 2000 | 958 | 0.160 |
Why?
|
| Potassium Channel Blockers | 2 | 2003 | 59 | 0.160 |
Why?
|
| Genes, Tumor Suppressor | 2 | 1998 | 156 | 0.160 |
Why?
|
| Pancreas, Exocrine | 1 | 2020 | 18 | 0.160 |
Why?
|
| Microcirculation | 1 | 2020 | 98 | 0.150 |
Why?
|
| Age of Onset | 3 | 2015 | 341 | 0.150 |
Why?
|
| Sodium | 3 | 2022 | 328 | 0.150 |
Why?
|
| PPAR gamma | 1 | 2020 | 75 | 0.150 |
Why?
|
| Child, Preschool | 6 | 2024 | 3781 | 0.150 |
Why?
|
| Endoderm | 1 | 1999 | 25 | 0.150 |
Why?
|
| Xenopus laevis | 4 | 1998 | 138 | 0.150 |
Why?
|
| Microscopy, Fluorescence | 6 | 2008 | 435 | 0.150 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2021 | 392 | 0.150 |
Why?
|
| Autoimmune Diseases | 1 | 2021 | 255 | 0.150 |
Why?
|
| Chromosome Mapping | 13 | 1997 | 1051 | 0.140 |
Why?
|
| Risk Factors | 3 | 2024 | 5900 | 0.140 |
Why?
|
| Cricetinae | 9 | 2008 | 532 | 0.140 |
Why?
|
| Pregnancy in Diabetics | 1 | 2018 | 41 | 0.140 |
Why?
|
| Virus Replication | 12 | 1983 | 284 | 0.140 |
Why?
|
| Cell Nucleus | 14 | 2006 | 601 | 0.140 |
Why?
|
| Kinetics | 19 | 2013 | 1463 | 0.140 |
Why?
|
| Biological Products | 1 | 2021 | 178 | 0.140 |
Why?
|
| Phosphoproteins | 3 | 1990 | 258 | 0.140 |
Why?
|
| Cohort Studies | 4 | 2018 | 3044 | 0.140 |
Why?
|
| Organ Transplantation | 1 | 2022 | 295 | 0.140 |
Why?
|
| GATA6 Transcription Factor | 1 | 2018 | 13 | 0.140 |
Why?
|
| Lamin Type A | 1 | 2018 | 26 | 0.130 |
Why?
|
| Nuclear Proteins | 4 | 2001 | 740 | 0.130 |
Why?
|
| Recombinant Proteins | 7 | 2015 | 981 | 0.130 |
Why?
|
| Ferrets | 2 | 2016 | 49 | 0.130 |
Why?
|
| Zebrafish | 2 | 2010 | 339 | 0.130 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2017 | 36 | 0.130 |
Why?
|
| Immune System Diseases | 1 | 2017 | 25 | 0.130 |
Why?
|
| Epitopes | 2 | 1995 | 249 | 0.130 |
Why?
|
| Molecular Weight | 23 | 1986 | 279 | 0.130 |
Why?
|
| Motor Neuron Disease | 1 | 1997 | 20 | 0.130 |
Why?
|
| Growth Inhibitors | 2 | 1995 | 41 | 0.130 |
Why?
|
| Cell Transformation, Viral | 8 | 1984 | 38 | 0.130 |
Why?
|
| Neural Conduction | 1 | 1997 | 71 | 0.130 |
Why?
|
| Pancreatitis, Chronic | 1 | 2017 | 54 | 0.130 |
Why?
|
| Glucose Clamp Technique | 2 | 2014 | 42 | 0.130 |
Why?
|
| DNA, Recombinant | 8 | 1988 | 60 | 0.130 |
Why?
|
| Potassium | 4 | 2009 | 224 | 0.130 |
Why?
|
| Pancreatic Neoplasms | 5 | 2007 | 714 | 0.130 |
Why?
|
| Tissue and Organ Procurement | 1 | 2022 | 389 | 0.130 |
Why?
|
| Tamoxifen | 3 | 2015 | 170 | 0.130 |
Why?
|
| Pregnancy Outcome | 1 | 2018 | 267 | 0.130 |
Why?
|
| DNA Restriction Enzymes | 16 | 1987 | 76 | 0.120 |
Why?
|
| Diarrhea | 1 | 2017 | 176 | 0.120 |
Why?
|
| Transferases | 3 | 1985 | 19 | 0.120 |
Why?
|
| Protein Kinase C | 1 | 2017 | 260 | 0.120 |
Why?
|
| CHO Cells | 5 | 2008 | 187 | 0.120 |
Why?
|
| Glycosyltransferases | 3 | 1985 | 20 | 0.120 |
Why?
|
| Xenopus Proteins | 3 | 1985 | 34 | 0.120 |
Why?
|
| Nucleoproteins | 4 | 1984 | 20 | 0.120 |
Why?
|
| Enterovirus | 5 | 2002 | 16 | 0.120 |
Why?
|
| Motor Neurons | 2 | 1997 | 176 | 0.120 |
Why?
|
| Pancreatectomy | 1 | 2017 | 168 | 0.120 |
Why?
|
| Genetic Vectors | 9 | 2003 | 422 | 0.120 |
Why?
|
| Carbachol | 2 | 2006 | 34 | 0.120 |
Why?
|
| Phosphatidylinositols | 1 | 2016 | 18 | 0.120 |
Why?
|
| Tumor Cells, Cultured | 8 | 2002 | 1022 | 0.120 |
Why?
|
| Selection Bias | 1 | 2016 | 37 | 0.120 |
Why?
|
| RNA, Small Nuclear | 8 | 1987 | 36 | 0.120 |
Why?
|
| Kidney Diseases | 1 | 1999 | 309 | 0.120 |
Why?
|
| Receptors, Gastrointestinal Hormone | 1 | 2015 | 9 | 0.120 |
Why?
|
| Reaction Time | 1 | 1997 | 316 | 0.120 |
Why?
|
| T Cell Transcription Factor 1 | 1 | 2015 | 23 | 0.120 |
Why?
|
| Hypothalamus | 1 | 2016 | 80 | 0.120 |
Why?
|
| Immunosuppressive Agents | 1 | 2021 | 987 | 0.120 |
Why?
|
| Dynamin II | 1 | 2015 | 15 | 0.120 |
Why?
|
| Cell Culture Techniques | 4 | 2021 | 195 | 0.120 |
Why?
|
| Cell Count | 1 | 2016 | 195 | 0.110 |
Why?
|
| Insulin, Regular, Human | 1 | 2015 | 6 | 0.110 |
Why?
|
| Fluorescent Antibody Technique | 4 | 2012 | 306 | 0.110 |
Why?
|
| Self-Help Groups | 1 | 2015 | 14 | 0.110 |
Why?
|
| Hepatocyte Nuclear Factor 4 | 2 | 2013 | 30 | 0.110 |
Why?
|
| Benzeneacetamides | 1 | 1995 | 11 | 0.110 |
Why?
|
| DNA Mutational Analysis | 4 | 2007 | 543 | 0.110 |
Why?
|
| Europe | 4 | 2020 | 338 | 0.110 |
Why?
|
| Pain, Postoperative | 1 | 2017 | 274 | 0.110 |
Why?
|
| Poliovirus | 9 | 1976 | 14 | 0.110 |
Why?
|
| Introns | 2 | 2015 | 298 | 0.110 |
Why?
|
| Nucleic Acid Hybridization | 22 | 1986 | 194 | 0.110 |
Why?
|
| Chicago | 3 | 2021 | 1452 | 0.110 |
Why?
|
| Gene Expression Regulation, Viral | 3 | 2001 | 87 | 0.110 |
Why?
|
| Saccharomyces cerevisiae Proteins | 2 | 1995 | 297 | 0.110 |
Why?
|
| Cystic Fibrosis | 1 | 2016 | 119 | 0.110 |
Why?
|
| Receptors, Serotonin | 1 | 2014 | 34 | 0.110 |
Why?
|
| Electrophysiology | 5 | 2021 | 389 | 0.110 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2015 | 296 | 0.110 |
Why?
|
| Quaternary Ammonium Compounds | 1 | 1995 | 81 | 0.110 |
Why?
|
| Adipocytes | 2 | 2006 | 169 | 0.110 |
Why?
|
| Cytomegalovirus | 2 | 2000 | 71 | 0.110 |
Why?
|
| Autoantibodies | 2 | 2024 | 276 | 0.110 |
Why?
|
| Trans-Activators | 3 | 2014 | 439 | 0.110 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2014 | 367 | 0.110 |
Why?
|
| Molecular Biology | 2 | 2010 | 83 | 0.110 |
Why?
|
| Intracellular Membranes | 3 | 2004 | 112 | 0.110 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 1995 | 71 | 0.110 |
Why?
|
| Tolbutamide | 3 | 2010 | 16 | 0.110 |
Why?
|
| Eukaryotic Initiation Factor-4G | 1 | 2014 | 3 | 0.110 |
Why?
|
| Carboxypeptidase H | 1 | 2014 | 12 | 0.110 |
Why?
|
| Glycolysis | 3 | 2004 | 186 | 0.110 |
Why?
|
| Receptors, Glucagon | 1 | 2014 | 11 | 0.110 |
Why?
|
| Xenopus | 8 | 1996 | 119 | 0.110 |
Why?
|
| Hormones | 2 | 2012 | 136 | 0.110 |
Why?
|
| Classification | 1 | 2014 | 55 | 0.100 |
Why?
|
| Glucuronosyltransferase | 3 | 1985 | 178 | 0.100 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 1995 | 191 | 0.100 |
Why?
|
| Stimulation, Chemical | 2 | 2012 | 54 | 0.100 |
Why?
|
| Graft Survival | 1 | 2018 | 939 | 0.100 |
Why?
|
| Minority Health | 1 | 2013 | 10 | 0.100 |
Why?
|
| Cell Line, Tumor | 5 | 2007 | 2757 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 11 | 2 | 1994 | 106 | 0.100 |
Why?
|
| Frameshift Mutation | 1 | 2013 | 50 | 0.100 |
Why?
|
| Mental Disorders | 2 | 2015 | 451 | 0.100 |
Why?
|
| Luciferases | 2 | 1993 | 128 | 0.100 |
Why?
|
| Cell Differentiation | 4 | 2006 | 1611 | 0.100 |
Why?
|
| Phosphorylation | 3 | 2015 | 1129 | 0.100 |
Why?
|
| Urban Health | 1 | 2013 | 54 | 0.100 |
Why?
|
| Homeodomain Proteins | 3 | 2014 | 556 | 0.100 |
Why?
|
| Stochastic Processes | 1 | 2013 | 75 | 0.100 |
Why?
|
| Serotonin | 1 | 2014 | 209 | 0.100 |
Why?
|
| Genetic Therapy | 3 | 2010 | 365 | 0.100 |
Why?
|
| Motion | 1 | 2013 | 95 | 0.100 |
Why?
|
| Family | 1 | 2015 | 319 | 0.100 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2013 | 72 | 0.100 |
Why?
|
| Microcephaly | 1 | 2013 | 77 | 0.100 |
Why?
|
| Genes, mos | 1 | 1993 | 2 | 0.100 |
Why?
|
| Pancreatitis | 1 | 2013 | 94 | 0.100 |
Why?
|
| Epilepsy, Generalized | 1 | 2013 | 42 | 0.100 |
Why?
|
| Point Mutation | 1 | 2013 | 237 | 0.090 |
Why?
|
| Genome-Wide Association Study | 3 | 2021 | 1763 | 0.090 |
Why?
|
| Signal Transduction | 9 | 2015 | 3497 | 0.090 |
Why?
|
| Capsid | 3 | 2000 | 20 | 0.090 |
Why?
|
| Capsid Proteins | 3 | 2000 | 26 | 0.090 |
Why?
|
| Up-Regulation | 2 | 2013 | 727 | 0.090 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2013 | 111 | 0.090 |
Why?
|
| Microtubules | 1 | 2013 | 134 | 0.090 |
Why?
|
| European Union | 1 | 1992 | 8 | 0.090 |
Why?
|
| Paracrine Communication | 1 | 2012 | 32 | 0.090 |
Why?
|
| Biological Science Disciplines | 1 | 1992 | 13 | 0.090 |
Why?
|
| Leptin | 2 | 2010 | 100 | 0.090 |
Why?
|
| Disease Management | 1 | 2014 | 357 | 0.090 |
Why?
|
| Prevalence | 3 | 2018 | 1318 | 0.090 |
Why?
|
| Thapsigargin | 5 | 2005 | 55 | 0.090 |
Why?
|
| Diagnosis, Differential | 1 | 2016 | 1519 | 0.090 |
Why?
|
| Data Interpretation, Statistical | 1 | 2013 | 305 | 0.090 |
Why?
|
| Alcoholism | 1 | 2013 | 188 | 0.090 |
Why?
|
| Ubiquitin-Conjugating Enzymes | 1 | 2012 | 32 | 0.090 |
Why?
|
| Biotinylation | 1 | 2012 | 42 | 0.090 |
Why?
|
| Dynorphins | 2 | 2006 | 14 | 0.090 |
Why?
|
| Blotting, Western | 5 | 2017 | 774 | 0.090 |
Why?
|
| Immunoprecipitation | 1 | 2012 | 136 | 0.090 |
Why?
|
| Biological Transport | 1 | 2012 | 398 | 0.090 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 8 | 2017 | 238 | 0.090 |
Why?
|
| Plasmids | 10 | 1993 | 272 | 0.090 |
Why?
|
| Epidemiologic Research Design | 1 | 2011 | 23 | 0.090 |
Why?
|
| Linkage Disequilibrium | 1 | 2013 | 478 | 0.090 |
Why?
|
| Pregnancy | 5 | 2024 | 3128 | 0.090 |
Why?
|
| Disease Models, Animal | 4 | 2013 | 2479 | 0.090 |
Why?
|
| Mutation, Missense | 2 | 2016 | 296 | 0.080 |
Why?
|
| Longitudinal Studies | 2 | 2013 | 1160 | 0.080 |
Why?
|
| Down-Regulation | 2 | 2012 | 523 | 0.080 |
Why?
|
| Genes, Reporter | 3 | 2010 | 275 | 0.080 |
Why?
|
| Species Specificity | 1 | 2013 | 683 | 0.080 |
Why?
|
| Potassium Chloride | 4 | 2005 | 75 | 0.080 |
Why?
|
| Fibroblasts | 7 | 2021 | 752 | 0.080 |
Why?
|
| Biology | 1 | 1991 | 51 | 0.080 |
Why?
|
| Sequence Homology, Nucleic Acid | 6 | 2000 | 157 | 0.080 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2013 | 453 | 0.080 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2011 | 101 | 0.080 |
Why?
|
| ARNTL Transcription Factors | 1 | 2010 | 13 | 0.080 |
Why?
|
| Cyclosporins | 1 | 1990 | 56 | 0.080 |
Why?
|
| Aminoquinolines | 1 | 2010 | 20 | 0.080 |
Why?
|
| Imines | 1 | 2010 | 5 | 0.080 |
Why?
|
| CLOCK Proteins | 1 | 2010 | 13 | 0.080 |
Why?
|
| AMP-Activated Protein Kinases | 2 | 2015 | 70 | 0.080 |
Why?
|
| Mice, Obese | 1 | 2010 | 49 | 0.080 |
Why?
|
| Research Support as Topic | 1 | 1991 | 89 | 0.080 |
Why?
|
| Saccharomycetales | 1 | 1990 | 15 | 0.080 |
Why?
|
| Injections, Intraperitoneal | 1 | 2010 | 102 | 0.080 |
Why?
|
| MyoD Protein | 1 | 1990 | 16 | 0.080 |
Why?
|
| Gene Targeting | 1 | 2010 | 72 | 0.080 |
Why?
|
| Blood Chemical Analysis | 1 | 2010 | 40 | 0.080 |
Why?
|
| Integrases | 1 | 2010 | 66 | 0.080 |
Why?
|
| Isoenzymes | 2 | 2009 | 271 | 0.080 |
Why?
|
| Naltrexone | 2 | 2006 | 139 | 0.080 |
Why?
|
| Vesicular Transport Proteins | 1 | 2010 | 70 | 0.080 |
Why?
|
| Amino Acid Substitution | 4 | 2016 | 331 | 0.080 |
Why?
|
| Schizosaccharomyces | 1 | 1990 | 56 | 0.080 |
Why?
|
| Quinolines | 1 | 2010 | 85 | 0.080 |
Why?
|
| Metabolism, Inborn Errors | 1 | 2009 | 30 | 0.080 |
Why?
|
| eIF-2 Kinase | 1 | 2010 | 50 | 0.080 |
Why?
|
| Phosphoric Diester Hydrolases | 2 | 2007 | 23 | 0.080 |
Why?
|
| DNA Replication | 7 | 1990 | 168 | 0.080 |
Why?
|
| Peptides | 10 | 2013 | 653 | 0.080 |
Why?
|
| Animals, Newborn | 2 | 2009 | 515 | 0.080 |
Why?
|
| Algorithms | 2 | 2011 | 1948 | 0.080 |
Why?
|
| Tooth Discoloration | 1 | 2009 | 2 | 0.070 |
Why?
|
| Cytoskeletal Proteins | 1 | 2010 | 222 | 0.070 |
Why?
|
| Evidence-Based Medicine | 2 | 2023 | 451 | 0.070 |
Why?
|
| Enzyme Activation | 2 | 2013 | 672 | 0.070 |
Why?
|
| Evoked Potentials | 1 | 2010 | 193 | 0.070 |
Why?
|
| Calcium Channels, L-Type | 1 | 2009 | 38 | 0.070 |
Why?
|
| Hyaluronoglucosaminidase | 2 | 1985 | 9 | 0.070 |
Why?
|
| Time | 1 | 2009 | 80 | 0.070 |
Why?
|
| Syndrome | 1 | 2010 | 432 | 0.070 |
Why?
|
| Biophysics | 2 | 2008 | 153 | 0.070 |
Why?
|
| Alternative Splicing | 4 | 2000 | 220 | 0.070 |
Why?
|
| Quantitative Trait Loci | 1 | 2013 | 630 | 0.070 |
Why?
|
| Heterozygote | 3 | 2018 | 381 | 0.070 |
Why?
|
| Chromosomes, Human | 2 | 1988 | 65 | 0.070 |
Why?
|
| Calcium-Transporting ATPases | 4 | 2003 | 27 | 0.070 |
Why?
|
| Stromal Interaction Molecule 1 | 1 | 2008 | 11 | 0.070 |
Why?
|
| Microfluidic Analytical Techniques | 1 | 2008 | 46 | 0.070 |
Why?
|
| Case-Control Studies | 3 | 2018 | 1925 | 0.070 |
Why?
|
| Boron Compounds | 1 | 2008 | 17 | 0.070 |
Why?
|
| Diabetes Complications | 2 | 2008 | 167 | 0.070 |
Why?
|
| Transplantation, Heterologous | 3 | 2021 | 371 | 0.070 |
Why?
|
| Coxsackievirus Infections | 1 | 2008 | 1 | 0.070 |
Why?
|
| Proto-Oncogene Proteins | 2 | 1988 | 663 | 0.070 |
Why?
|
| Nanostructures | 1 | 2009 | 89 | 0.070 |
Why?
|
| Circadian Rhythm | 1 | 2010 | 285 | 0.070 |
Why?
|
| Immunohistochemistry | 5 | 2016 | 1786 | 0.070 |
Why?
|
| Quality-Adjusted Life Years | 2 | 2022 | 157 | 0.070 |
Why?
|
| Antibodies | 3 | 2003 | 346 | 0.070 |
Why?
|
| Group IV Phospholipases A2 | 1 | 2007 | 9 | 0.070 |
Why?
|
| Tissue Culture Techniques | 4 | 2015 | 80 | 0.070 |
Why?
|
| Oligodendroglioma | 2 | 1985 | 42 | 0.070 |
Why?
|
| Periodicals as Topic | 1 | 1989 | 166 | 0.070 |
Why?
|
| Genetic Techniques | 1 | 1988 | 74 | 0.070 |
Why?
|
| Genomics | 1 | 2013 | 848 | 0.070 |
Why?
|
| Congresses as Topic | 2 | 2020 | 121 | 0.070 |
Why?
|
| Venoms | 2 | 2020 | 11 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2009 | 364 | 0.060 |
Why?
|
| Immediate-Early Proteins | 1 | 1988 | 161 | 0.060 |
Why?
|
| Artificial Limbs | 1 | 1987 | 17 | 0.060 |
Why?
|
| Adenylyl Cyclases | 1 | 2007 | 105 | 0.060 |
Why?
|
| Phospholipids | 1 | 2007 | 106 | 0.060 |
Why?
|
| Proteoglycans | 2 | 1985 | 75 | 0.060 |
Why?
|
| Carcinoma | 7 | 2002 | 439 | 0.060 |
Why?
|
| Genes, Regulator | 1 | 1987 | 59 | 0.060 |
Why?
|
| Blood Substitutes | 1 | 2006 | 7 | 0.060 |
Why?
|
| Pyridoxal Phosphate | 1 | 2006 | 11 | 0.060 |
Why?
|
| Phospholipases A | 1 | 2006 | 45 | 0.060 |
Why?
|
| Neurosecretory Systems | 1 | 2007 | 35 | 0.060 |
Why?
|
| Obesity | 1 | 2013 | 1014 | 0.060 |
Why?
|
| Time Factors | 12 | 2006 | 5380 | 0.060 |
Why?
|
| Incidence | 1 | 2011 | 1697 | 0.060 |
Why?
|
| Cell Movement | 1 | 2010 | 804 | 0.060 |
Why?
|
| Polymerase Chain Reaction | 4 | 1994 | 888 | 0.060 |
Why?
|
| Protein Binding | 5 | 2006 | 1526 | 0.060 |
Why?
|
| Chronic Disease | 1 | 2009 | 941 | 0.060 |
Why?
|
| Protein Transport | 1 | 2008 | 438 | 0.060 |
Why?
|
| Societies, Medical | 2 | 2020 | 618 | 0.060 |
Why?
|
| Uncoupling Agents | 1 | 2006 | 15 | 0.060 |
Why?
|
| 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer | 1 | 2006 | 10 | 0.060 |
Why?
|
| Endonucleases | 4 | 1982 | 21 | 0.060 |
Why?
|
| Reference Values | 4 | 2006 | 603 | 0.060 |
Why?
|
| Microinjections | 4 | 1991 | 67 | 0.060 |
Why?
|
| Indians, North American | 1 | 2006 | 48 | 0.060 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2006 | 74 | 0.060 |
Why?
|
| Temperature | 7 | 2004 | 421 | 0.060 |
Why?
|
| Sequence Alignment | 3 | 2000 | 348 | 0.060 |
Why?
|
| Oxidative Phosphorylation | 1 | 2006 | 58 | 0.060 |
Why?
|
| Tetraethylammonium Compounds | 2 | 1996 | 13 | 0.060 |
Why?
|
| Hemoglobins | 1 | 2006 | 188 | 0.060 |
Why?
|
| Aged | 4 | 2022 | 20395 | 0.060 |
Why?
|
| Analgesia, Epidural | 2 | 1996 | 42 | 0.060 |
Why?
|
| Mice, Inbred NOD | 1 | 2006 | 218 | 0.060 |
Why?
|
| Blotting, Northern | 4 | 1994 | 239 | 0.060 |
Why?
|
| Epilepsy | 1 | 2010 | 434 | 0.060 |
Why?
|
| Mice, SCID | 1 | 2006 | 271 | 0.060 |
Why?
|
| Prognosis | 3 | 2018 | 3890 | 0.060 |
Why?
|
| Nitric Oxide | 1 | 2007 | 281 | 0.060 |
Why?
|
| Fluorescein-5-isothiocyanate | 3 | 1991 | 27 | 0.060 |
Why?
|
| Multidrug Resistance-Associated Proteins | 1 | 2005 | 25 | 0.060 |
Why?
|
| Hepatocytes | 1 | 2006 | 129 | 0.060 |
Why?
|
| Thiobarbiturates | 1 | 2005 | 5 | 0.060 |
Why?
|
| Neurologic Manifestations | 2 | 2016 | 10 | 0.060 |
Why?
|
| Disease Progression | 1 | 2009 | 1529 | 0.060 |
Why?
|
| Fluorescent Dyes | 2 | 2006 | 255 | 0.060 |
Why?
|
| Rural Population | 1 | 2006 | 170 | 0.060 |
Why?
|
| Oscillometry | 1 | 2005 | 25 | 0.060 |
Why?
|
| Patient Participation | 1 | 2007 | 229 | 0.060 |
Why?
|
| Diet, High-Fat | 2 | 2017 | 135 | 0.060 |
Why?
|
| Rats, Zucker | 2 | 2003 | 38 | 0.060 |
Why?
|
| Coloring Agents | 1 | 2005 | 65 | 0.060 |
Why?
|
| Urban Population | 1 | 2006 | 234 | 0.050 |
Why?
|
| Feedback | 1 | 2005 | 129 | 0.050 |
Why?
|
| Liver | 6 | 2002 | 1206 | 0.050 |
Why?
|
| Cartilage | 1 | 1985 | 71 | 0.050 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2013 | 2484 | 0.050 |
Why?
|
| Cell Survival | 4 | 2010 | 1002 | 0.050 |
Why?
|
| Enhancer Elements, Genetic | 1 | 1987 | 293 | 0.050 |
Why?
|
| Inhibitor of Differentiation Protein 1 | 2 | 1994 | 8 | 0.050 |
Why?
|
| Lipid Metabolism | 1 | 2006 | 214 | 0.050 |
Why?
|
| Drug Synergism | 1 | 2005 | 313 | 0.050 |
Why?
|
| Autoimmunity | 1 | 2006 | 191 | 0.050 |
Why?
|
| Adenoviridae Infections | 3 | 2001 | 16 | 0.050 |
Why?
|
| Peptide Fragments | 4 | 2005 | 468 | 0.050 |
Why?
|
| Antioxidants | 1 | 2005 | 231 | 0.050 |
Why?
|
| Membrane Fusion | 1 | 2004 | 37 | 0.050 |
Why?
|
| Hemagglutination | 4 | 1964 | 7 | 0.050 |
Why?
|
| Enzyme Induction | 3 | 2013 | 83 | 0.050 |
Why?
|
| Computational Biology | 1 | 2007 | 581 | 0.050 |
Why?
|
| Prospective Studies | 2 | 2024 | 4546 | 0.050 |
Why?
|
| Cellular Senescence | 2 | 1995 | 106 | 0.050 |
Why?
|
| Dequalinium | 1 | 2003 | 3 | 0.050 |
Why?
|
| Intermediate-Conductance Calcium-Activated Potassium Channels | 1 | 2003 | 4 | 0.050 |
Why?
|
| Apamin | 1 | 2003 | 4 | 0.050 |
Why?
|
| Charybdotoxin | 1 | 2003 | 8 | 0.050 |
Why?
|
| Microscopy, Electron | 7 | 2008 | 429 | 0.050 |
Why?
|
| Mice, Nude | 2 | 2021 | 823 | 0.050 |
Why?
|
| Research Design | 1 | 2007 | 620 | 0.050 |
Why?
|
| Protein Folding | 3 | 2013 | 291 | 0.050 |
Why?
|
| Small-Conductance Calcium-Activated Potassium Channels | 1 | 2003 | 15 | 0.050 |
Why?
|
| Stem Cells | 1 | 2006 | 386 | 0.050 |
Why?
|
| Transgenes | 2 | 2013 | 171 | 0.050 |
Why?
|
| Gene Library | 2 | 2002 | 124 | 0.050 |
Why?
|
| Sodium-Calcium Exchanger | 1 | 2003 | 21 | 0.050 |
Why?
|
| Calcium Channels, R-Type | 2 | 2000 | 4 | 0.050 |
Why?
|
| Cell Transformation, Neoplastic | 5 | 1990 | 456 | 0.050 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2024 | 3450 | 0.050 |
Why?
|
| Intercalating Agents | 1 | 2003 | 11 | 0.050 |
Why?
|
| rab3A GTP-Binding Protein | 1 | 2003 | 4 | 0.050 |
Why?
|
| Ethidium | 1 | 2003 | 13 | 0.050 |
Why?
|
| Aspartic Acid Endopeptidases | 1 | 2003 | 69 | 0.050 |
Why?
|
| Image Enhancement | 1 | 2006 | 498 | 0.050 |
Why?
|
| Sodium-Glucose Transporter 2 | 1 | 2022 | 6 | 0.050 |
Why?
|
| Actin Cytoskeleton | 2 | 2015 | 196 | 0.050 |
Why?
|
| Recombination, Genetic | 2 | 2000 | 420 | 0.050 |
Why?
|
| Growth Substances | 3 | 1994 | 79 | 0.050 |
Why?
|
| Remission Induction | 1 | 2024 | 737 | 0.050 |
Why?
|
| Glycoproteins | 3 | 1982 | 216 | 0.050 |
Why?
|
| Muscle, Skeletal | 1 | 2006 | 473 | 0.050 |
Why?
|
| Cytokines | 2 | 2016 | 862 | 0.050 |
Why?
|
| Cytoplasmic Granules | 2 | 2015 | 94 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2015 | 1908 | 0.050 |
Why?
|
| Combined Modality Therapy | 1 | 2006 | 1719 | 0.050 |
Why?
|
| TRPM Cation Channels | 1 | 2002 | 8 | 0.050 |
Why?
|
| Tritium | 9 | 1984 | 113 | 0.050 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2026 | 538 | 0.040 |
Why?
|
| Cations | 1 | 2002 | 29 | 0.040 |
Why?
|
| Retrospective Studies | 4 | 2018 | 10128 | 0.040 |
Why?
|
| Sequence Homology, Amino Acid | 3 | 1997 | 402 | 0.040 |
Why?
|
| Nutrition Surveys | 1 | 2022 | 125 | 0.040 |
Why?
|
| TRPC Cation Channels | 1 | 2002 | 24 | 0.040 |
Why?
|
| Reproducibility of Results | 2 | 2010 | 2705 | 0.040 |
Why?
|
| Pedigree | 3 | 2008 | 962 | 0.040 |
Why?
|
| Proteins | 2 | 1999 | 790 | 0.040 |
Why?
|
| Internationality | 1 | 2022 | 78 | 0.040 |
Why?
|
| Nucleic Acid Conformation | 3 | 1984 | 341 | 0.040 |
Why?
|
| Muscle, Smooth | 1 | 2002 | 299 | 0.040 |
Why?
|
| Escherichia coli | 8 | 1986 | 562 | 0.040 |
Why?
|
| Crosses, Genetic | 2 | 2013 | 165 | 0.040 |
Why?
|
| Xylenes | 1 | 2021 | 4 | 0.040 |
Why?
|
| Staphylococcal Protein A | 4 | 1986 | 41 | 0.040 |
Why?
|
| Elastic Modulus | 1 | 2021 | 34 | 0.040 |
Why?
|
| Staphylococcus Phages | 1 | 1981 | 1 | 0.040 |
Why?
|
| Mechanical Phenomena | 1 | 2021 | 18 | 0.040 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2008 | 1269 | 0.040 |
Why?
|
| Cricetulus | 2 | 2008 | 122 | 0.040 |
Why?
|
| Oxygen | 2 | 2003 | 749 | 0.040 |
Why?
|
| GPI-Linked Proteins | 3 | 1997 | 55 | 0.040 |
Why?
|
| Cell Separation | 3 | 2006 | 199 | 0.040 |
Why?
|
| Adenine Nucleotides | 5 | 1978 | 57 | 0.040 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 3 | 1994 | 128 | 0.040 |
Why?
|
| United States Food and Drug Administration | 1 | 2022 | 139 | 0.040 |
Why?
|
| Sex Factors | 2 | 2015 | 1102 | 0.040 |
Why?
|
| Expert Testimony | 1 | 2020 | 34 | 0.040 |
Why?
|
| RNA, Small Nucleolar | 1 | 2000 | 8 | 0.040 |
Why?
|
| Oncogenes | 3 | 1988 | 100 | 0.040 |
Why?
|
| Protein Conformation | 5 | 2008 | 907 | 0.040 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2021 | 208 | 0.040 |
Why?
|
| Centrifugation, Density Gradient | 9 | 1976 | 93 | 0.040 |
Why?
|
| Costs and Cost Analysis | 1 | 2021 | 154 | 0.040 |
Why?
|
| Financial Management | 1 | 2020 | 21 | 0.040 |
Why?
|
| Monitoring, Ambulatory | 1 | 2020 | 32 | 0.040 |
Why?
|
| Adipose Tissue | 1 | 2002 | 268 | 0.040 |
Why?
|
| Arginine | 3 | 2003 | 140 | 0.040 |
Why?
|
| Staphylococcus aureus | 4 | 1985 | 284 | 0.040 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 1981 | 123 | 0.040 |
Why?
|
| Treatment Outcome | 3 | 2018 | 9070 | 0.040 |
Why?
|
| DNA Methylation | 1 | 2024 | 699 | 0.040 |
Why?
|
| Health Plan Implementation | 1 | 2020 | 62 | 0.040 |
Why?
|
| Binding Sites | 3 | 2003 | 1126 | 0.040 |
Why?
|
| DNA Primers | 3 | 1995 | 528 | 0.040 |
Why?
|
| Phosphorus Isotopes | 5 | 1973 | 14 | 0.040 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2021 | 135 | 0.040 |
Why?
|
| Capillaries | 1 | 2020 | 83 | 0.040 |
Why?
|
| Neural Pathways | 1 | 2021 | 324 | 0.040 |
Why?
|
| Ribonucleases | 5 | 1996 | 88 | 0.040 |
Why?
|
| Virus Cultivation | 4 | 1973 | 14 | 0.040 |
Why?
|
| Printing, Three-Dimensional | 1 | 2020 | 50 | 0.040 |
Why?
|
| DNA Helicases | 1 | 1980 | 90 | 0.040 |
Why?
|
| Double-Blind Method | 2 | 2021 | 1727 | 0.040 |
Why?
|
| Structure-Activity Relationship | 4 | 1994 | 422 | 0.040 |
Why?
|
| Chromatography | 4 | 1968 | 25 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2000 | 203 | 0.040 |
Why?
|
| Biomarkers | 2 | 2017 | 1905 | 0.040 |
Why?
|
| Cell Cycle Proteins | 3 | 1997 | 409 | 0.030 |
Why?
|
| Birth Weight | 1 | 2018 | 148 | 0.030 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2002 | 376 | 0.030 |
Why?
|
| Receptors, Neuropeptide Y | 1 | 1998 | 3 | 0.030 |
Why?
|
| Defective Viruses | 1 | 1978 | 10 | 0.030 |
Why?
|
| Health Equity | 1 | 2020 | 101 | 0.030 |
Why?
|
| Neuropeptide Y | 1 | 1998 | 29 | 0.030 |
Why?
|
| Abortion, Spontaneous | 1 | 2018 | 73 | 0.030 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2020 | 279 | 0.030 |
Why?
|
| Monocyte Chemoattractant Proteins | 1 | 1997 | 2 | 0.030 |
Why?
|
| Protein Subunits | 2 | 2013 | 120 | 0.030 |
Why?
|
| Receptors, Chemokine | 1 | 1997 | 30 | 0.030 |
Why?
|
| Cellular Reprogramming | 1 | 2018 | 50 | 0.030 |
Why?
|
| Nerve Net | 1 | 2021 | 394 | 0.030 |
Why?
|
| Chemokine CCL2 | 1 | 1997 | 45 | 0.030 |
Why?
|
| Morphogenesis | 1 | 1999 | 204 | 0.030 |
Why?
|
| Drug Resistance | 2 | 2017 | 231 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2010 | 885 | 0.030 |
Why?
|
| Hydrogen-Ion Concentration | 5 | 2009 | 479 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2017 | 336 | 0.030 |
Why?
|
| Public Policy | 1 | 1977 | 59 | 0.030 |
Why?
|
| 4-Aminopyridine | 1 | 1996 | 33 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 1997 | 151 | 0.030 |
Why?
|
| Hyaluronan Synthases | 3 | 1985 | 6 | 0.030 |
Why?
|
| Hybrid Cells | 2 | 1994 | 68 | 0.030 |
Why?
|
| Autopsy | 1 | 2017 | 126 | 0.030 |
Why?
|
| Transplantation, Autologous | 1 | 2017 | 359 | 0.030 |
Why?
|
| Ventromedial Hypothalamic Nucleus | 1 | 2016 | 5 | 0.030 |
Why?
|
| Hypothalamic Area, Lateral | 1 | 2016 | 10 | 0.030 |
Why?
|
| Axons | 1 | 1997 | 176 | 0.030 |
Why?
|
| Arcuate Nucleus of Hypothalamus | 1 | 2016 | 17 | 0.030 |
Why?
|
| Mouth Neoplasms | 6 | 1975 | 202 | 0.030 |
Why?
|
| Gene Expression Profiling | 2 | 2013 | 1517 | 0.030 |
Why?
|
| Cell Proliferation | 2 | 2013 | 1732 | 0.030 |
Why?
|
| Rhinovirus | 1 | 1976 | 29 | 0.030 |
Why?
|
| Protein Structure, Tertiary | 2 | 2008 | 726 | 0.030 |
Why?
|
| Evoked Potentials, Somatosensory | 1 | 1996 | 27 | 0.030 |
Why?
|
| Sensory Thresholds | 1 | 1996 | 51 | 0.030 |
Why?
|
| Amides | 1 | 1996 | 54 | 0.030 |
Why?
|
| Siblings | 1 | 2016 | 108 | 0.030 |
Why?
|
| Clathrin-Coated Vesicles | 1 | 2015 | 10 | 0.030 |
Why?
|
| Vaccinia virus | 2 | 1988 | 20 | 0.030 |
Why?
|
| Chlorides | 3 | 2009 | 100 | 0.030 |
Why?
|
| Anesthesia, Epidural | 1 | 1996 | 33 | 0.030 |
Why?
|
| Gene Knockout Techniques | 1 | 2015 | 83 | 0.030 |
Why?
|
| Bupivacaine | 1 | 1996 | 48 | 0.030 |
Why?
|
| Pain Management | 1 | 2017 | 180 | 0.030 |
Why?
|
| Biomedical Research | 1 | 2020 | 432 | 0.030 |
Why?
|
| G Protein-Coupled Inwardly-Rectifying Potassium Channels | 1 | 1995 | 9 | 0.030 |
Why?
|
| Enkephalin, D-Penicillamine (2,5)- | 1 | 1995 | 3 | 0.030 |
Why?
|
| RNA, Complementary | 1 | 1995 | 8 | 0.030 |
Why?
|
| Virulence Factors, Bordetella | 1 | 1995 | 25 | 0.030 |
Why?
|
| Protein Structure, Secondary | 1 | 1996 | 337 | 0.030 |
Why?
|
| Pertussis Toxin | 1 | 1995 | 31 | 0.030 |
Why?
|
| Enkephalin, Ala(2)-MePhe(4)-Gly(5)- | 1 | 1995 | 21 | 0.030 |
Why?
|
| Dextrans | 5 | 1991 | 77 | 0.030 |
Why?
|
| ROC Curve | 1 | 2017 | 774 | 0.030 |
Why?
|
| Genes, jun | 1 | 1995 | 18 | 0.030 |
Why?
|
| Receptors, Platelet-Derived Growth Factor | 1 | 1995 | 17 | 0.030 |
Why?
|
| Genes, fos | 1 | 1995 | 24 | 0.030 |
Why?
|
| Genes, Immediate-Early | 1 | 1995 | 17 | 0.030 |
Why?
|
| Immunodiffusion | 4 | 1977 | 23 | 0.030 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 1995 | 65 | 0.030 |
Why?
|
| Philadelphia | 1 | 2015 | 26 | 0.030 |
Why?
|
| Adenovirus E3 Proteins | 1 | 1995 | 2 | 0.030 |
Why?
|
| Anesthetics, Local | 1 | 1996 | 83 | 0.030 |
Why?
|
| Adenovirus E1A Proteins | 1 | 1995 | 8 | 0.030 |
Why?
|
| Genes, myc | 1 | 1995 | 37 | 0.030 |
Why?
|
| Tryptophan Hydroxylase | 1 | 2014 | 11 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 1996 | 710 | 0.030 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2020 | 618 | 0.030 |
Why?
|
| Pancreatic Diseases | 1 | 1995 | 58 | 0.030 |
Why?
|
| Naloxone | 1 | 1995 | 72 | 0.030 |
Why?
|
| Mutagenesis, Site-Directed | 3 | 2003 | 268 | 0.030 |
Why?
|
| Glutamic Acid | 1 | 2015 | 135 | 0.030 |
Why?
|
| Transcription Factor 7-Like 1 Protein | 1 | 1994 | 6 | 0.030 |
Why?
|
| Pyrrolidines | 1 | 1995 | 61 | 0.030 |
Why?
|
| Sulfhydryl Compounds | 2 | 2007 | 67 | 0.030 |
Why?
|
| Coxsackie and Adenovirus Receptor-Like Membrane Protein | 2 | 2008 | 12 | 0.030 |
Why?
|
| TCF Transcription Factors | 1 | 1994 | 24 | 0.030 |
Why?
|
| Genes, Bacterial | 3 | 1984 | 150 | 0.030 |
Why?
|
| Endocytosis | 1 | 2015 | 184 | 0.030 |
Why?
|
| Peptide Biosynthesis | 4 | 1980 | 13 | 0.030 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 1 | 2014 | 12 | 0.030 |
Why?
|
| Cell Membrane Permeability | 1 | 1995 | 121 | 0.030 |
Why?
|
| Dipeptidyl Peptidase 4 | 1 | 2014 | 7 | 0.030 |
Why?
|
| Ribonucleoproteins, Small Nuclear | 3 | 1988 | 20 | 0.030 |
Why?
|
| Tissue Donors | 1 | 2018 | 541 | 0.030 |
Why?
|
| Cycloleucine | 1 | 1994 | 10 | 0.030 |
Why?
|
| Kainic Acid | 1 | 1994 | 23 | 0.030 |
Why?
|
| Receptors, Muscarinic | 1 | 1994 | 42 | 0.030 |
Why?
|
| Receptors, Glutamate | 1 | 1994 | 22 | 0.030 |
Why?
|
| Receptor, Insulin | 1 | 2014 | 60 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 2 | 1 | 1994 | 85 | 0.030 |
Why?
|
| Myocardium | 2 | 1995 | 567 | 0.030 |
Why?
|
| Neuropsychological Tests | 1 | 2016 | 541 | 0.030 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 1994 | 37 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2021 | 2434 | 0.030 |
Why?
|
| Neurotoxins | 1 | 1994 | 44 | 0.030 |
Why?
|
| Cation Transport Proteins | 1 | 1994 | 61 | 0.030 |
Why?
|
| Calcineurin | 1 | 2013 | 19 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 1 | 2015 | 257 | 0.030 |
Why?
|
| Blindness, Cortical | 1 | 2013 | 8 | 0.030 |
Why?
|
| Colloids | 1 | 2013 | 28 | 0.030 |
Why?
|
| Neuroglia | 1 | 1994 | 77 | 0.030 |
Why?
|
| NAD | 1 | 1994 | 96 | 0.030 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2014 | 91 | 0.030 |
Why?
|
| Isoflurane | 1 | 2014 | 57 | 0.020 |
Why?
|
| Estrogens | 1 | 1994 | 194 | 0.020 |
Why?
|
| Enterovirus C, Human | 2 | 1963 | 2 | 0.020 |
Why?
|
| Needs Assessment | 1 | 2015 | 167 | 0.020 |
Why?
|
| Glycosaminoglycans | 2 | 1984 | 31 | 0.020 |
Why?
|
| Erythrocytes | 2 | 1964 | 235 | 0.020 |
Why?
|
| Electrons | 2 | 1964 | 51 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 1997 | 657 | 0.020 |
Why?
|
| Anxiety Disorders | 1 | 2014 | 155 | 0.020 |
Why?
|
| Tissue Extracts | 2 | 1975 | 24 | 0.020 |
Why?
|
| Culture Techniques | 2 | 1975 | 80 | 0.020 |
Why?
|
| Avian Leukosis Virus | 2 | 1983 | 4 | 0.020 |
Why?
|
| Animals, Genetically Modified | 1 | 2013 | 186 | 0.020 |
Why?
|
| Immunoblotting | 1 | 1993 | 273 | 0.020 |
Why?
|
| Neoplasms | 1 | 1988 | 3168 | 0.020 |
Why?
|
| Microscopy | 2 | 1964 | 88 | 0.020 |
Why?
|
| Terminator Regions, Genetic | 1 | 1993 | 12 | 0.020 |
Why?
|
| Orthomyxoviridae | 2 | 1964 | 46 | 0.020 |
Why?
|
| Eye | 1 | 2013 | 108 | 0.020 |
Why?
|
| Tubulin Modulators | 1 | 2013 | 23 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2018 | 1849 | 0.020 |
Why?
|
| Biological Transport, Active | 1 | 2013 | 98 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2017 | 1703 | 0.020 |
Why?
|
| Conserved Sequence | 1 | 1993 | 209 | 0.020 |
Why?
|
| Vinblastine | 1 | 2013 | 84 | 0.020 |
Why?
|
| Restriction Mapping | 1 | 1993 | 119 | 0.020 |
Why?
|
| Wings, Animal | 1 | 2013 | 104 | 0.020 |
Why?
|
| In Situ Hybridization | 1 | 1993 | 303 | 0.020 |
Why?
|
| Gene Dosage | 1 | 2013 | 211 | 0.020 |
Why?
|
| Fatal Outcome | 1 | 2013 | 292 | 0.020 |
Why?
|
| Brain Mapping | 1 | 2016 | 565 | 0.020 |
Why?
|
| Quantitative Trait, Heritable | 1 | 2013 | 125 | 0.020 |
Why?
|
| Pentosyltransferases | 2 | 1985 | 17 | 0.020 |
Why?
|
| Cell Death | 1 | 2013 | 252 | 0.020 |
Why?
|
| RNA, Heterogeneous Nuclear | 2 | 1982 | 2 | 0.020 |
Why?
|
| Tobacco Mosaic Virus | 1 | 1972 | 1 | 0.020 |
Why?
|
| National Institutes of Health (U.S.) | 2 | 1988 | 135 | 0.020 |
Why?
|
| Health Status | 1 | 2015 | 373 | 0.020 |
Why?
|
| Chondroitin Sulfates | 2 | 1985 | 27 | 0.020 |
Why?
|
| Electric Stimulation | 2 | 2008 | 344 | 0.020 |
Why?
|
| Anisomycin | 2 | 1983 | 9 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2013 | 391 | 0.020 |
Why?
|
| Growth | 2 | 1992 | 42 | 0.020 |
Why?
|
| Mutant Proteins | 1 | 2013 | 98 | 0.020 |
Why?
|
| Embryonic and Fetal Development | 1 | 1992 | 66 | 0.020 |
Why?
|
| Chymotrypsin | 2 | 1980 | 28 | 0.020 |
Why?
|
| Depressive Disorder, Major | 1 | 2014 | 171 | 0.020 |
Why?
|
| Dogs | 1 | 1993 | 632 | 0.020 |
Why?
|
| Actins | 1 | 2015 | 467 | 0.020 |
Why?
|
| Macromolecular Substances | 4 | 1994 | 161 | 0.020 |
Why?
|
| RNA, Ribosomal | 4 | 1982 | 65 | 0.020 |
Why?
|
| Carbon Radioisotopes | 4 | 1984 | 28 | 0.020 |
Why?
|
| Feeding and Eating Disorders | 1 | 2014 | 185 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2014 | 883 | 0.020 |
Why?
|
| Histidine | 1 | 1972 | 69 | 0.020 |
Why?
|
| Chromatography, Gel | 3 | 1979 | 94 | 0.020 |
Why?
|
| Mitosis | 1 | 1992 | 151 | 0.020 |
Why?
|
| Mink | 1 | 1991 | 3 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2015 | 891 | 0.020 |
Why?
|
| Cattle | 3 | 1990 | 392 | 0.020 |
Why?
|
| Patient Education as Topic | 1 | 2015 | 381 | 0.020 |
Why?
|
| Financing, Government | 1 | 1991 | 24 | 0.020 |
Why?
|
| Organizations | 1 | 1991 | 17 | 0.020 |
Why?
|
| Transduction, Genetic | 2 | 2002 | 160 | 0.020 |
Why?
|
| Oligonucleotide Probes | 1 | 1991 | 36 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2007 | 215 | 0.020 |
Why?
|
| Hydrolysis | 3 | 1985 | 140 | 0.020 |
Why?
|
| Mice, Inbred Strains | 2 | 2006 | 279 | 0.020 |
Why?
|
| Politics | 1 | 1991 | 51 | 0.020 |
Why?
|
| Amino Acids | 4 | 1979 | 245 | 0.020 |
Why?
|
| Galactosides | 1 | 2010 | 6 | 0.020 |
Why?
|
| Neurons | 2 | 2000 | 1568 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2018 | 3814 | 0.020 |
Why?
|
| Peptidylprolyl Isomerase | 1 | 1990 | 9 | 0.020 |
Why?
|
| Comorbidity | 1 | 2014 | 1003 | 0.020 |
Why?
|
| Period Circadian Proteins | 1 | 2010 | 13 | 0.020 |
Why?
|
| Estrogen Antagonists | 1 | 2010 | 47 | 0.020 |
Why?
|
| Cell-Free System | 2 | 1975 | 45 | 0.020 |
Why?
|
| Glucose Oxidase | 1 | 2010 | 7 | 0.020 |
Why?
|
| Polymorphism, Genetic | 1 | 1994 | 826 | 0.020 |
Why?
|
| Age Factors | 1 | 2015 | 1898 | 0.020 |
Why?
|
| Genes, Fungal | 1 | 1990 | 62 | 0.020 |
Why?
|
| Hepatocyte Nuclear Factor 1 | 2 | 2001 | 30 | 0.020 |
Why?
|
| Hepatocyte Nuclear Factor 1-beta | 2 | 2001 | 34 | 0.020 |
Why?
|
| Hematocrit | 1 | 2010 | 65 | 0.020 |
Why?
|
| Cell Size | 1 | 2010 | 71 | 0.020 |
Why?
|
| Synaptic Vesicles | 1 | 2010 | 39 | 0.020 |
Why?
|
| Blood Specimen Collection | 1 | 2010 | 28 | 0.020 |
Why?
|
| Nucleic Acids | 2 | 1973 | 35 | 0.020 |
Why?
|
| Haplorhini | 2 | 1975 | 77 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2013 | 806 | 0.020 |
Why?
|
| Genetic Engineering | 2 | 1988 | 99 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2013 | 406 | 0.020 |
Why?
|
| Cerebral Cortex | 1 | 1994 | 569 | 0.020 |
Why?
|
| Oligodeoxyribonucleotides | 3 | 1987 | 125 | 0.020 |
Why?
|
| DNA Transposable Elements | 3 | 1986 | 168 | 0.020 |
Why?
|
| Wakefulness | 1 | 2010 | 128 | 0.020 |
Why?
|
| Myosins | 1 | 1990 | 86 | 0.020 |
Why?
|
| Antigens, Viral | 3 | 1975 | 122 | 0.020 |
Why?
|
| Dental Enamel Hypoplasia | 1 | 2009 | 2 | 0.020 |
Why?
|
| DNA, Neoplasm | 2 | 1988 | 266 | 0.020 |
Why?
|
| Calcium Channel Blockers | 2 | 2000 | 118 | 0.020 |
Why?
|
| Ultracentrifugation | 2 | 1969 | 34 | 0.020 |
Why?
|
| DNA Fragmentation | 2 | 2000 | 65 | 0.020 |
Why?
|
| Membranes, Artificial | 1 | 2009 | 38 | 0.020 |
Why?
|
| Swine | 1 | 2010 | 585 | 0.020 |
Why?
|
| Drosophila melanogaster | 1 | 2013 | 629 | 0.020 |
Why?
|
| Oncogenic Viruses | 1 | 1988 | 4 | 0.020 |
Why?
|
| Cocarcinogenesis | 1 | 1988 | 11 | 0.020 |
Why?
|
| Mutagenesis | 2 | 1996 | 192 | 0.020 |
Why?
|
| Proto-Oncogenes | 1 | 1988 | 60 | 0.020 |
Why?
|
| Microelectrodes | 1 | 2008 | 86 | 0.020 |
Why?
|
| Radiometry | 2 | 1969 | 60 | 0.020 |
Why?
|
| Operon | 3 | 1984 | 34 | 0.020 |
Why?
|
| Uridine | 4 | 1973 | 54 | 0.020 |
Why?
|
| Immunoglobulin G | 1 | 2010 | 465 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 1988 | 66 | 0.020 |
Why?
|
| DNA-Directed DNA Polymerase | 1 | 1988 | 22 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2005 | 1236 | 0.020 |
Why?
|
| Genetic Linkage | 2 | 2007 | 613 | 0.020 |
Why?
|
| Carcinogens | 1 | 1988 | 101 | 0.020 |
Why?
|
| Norway | 1 | 2008 | 10 | 0.020 |
Why?
|
| Transcriptome | 1 | 2013 | 762 | 0.020 |
Why?
|
| Societies, Scientific | 1 | 1988 | 41 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2013 | 1910 | 0.020 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2007 | 23 | 0.020 |
Why?
|
| Ganglia, Spinal | 2 | 2000 | 72 | 0.020 |
Why?
|
| Molecular Conformation | 1 | 2008 | 111 | 0.020 |
Why?
|
| Japan | 1 | 1988 | 299 | 0.020 |
Why?
|
| Kv1.2 Potassium Channel | 1 | 2007 | 23 | 0.020 |
Why?
|
| Databases, Factual | 1 | 1992 | 1004 | 0.020 |
Why?
|
| RNA Splicing | 3 | 1988 | 157 | 0.020 |
Why?
|
| Models, Molecular | 2 | 2003 | 1353 | 0.020 |
Why?
|
| Simian virus 40 | 1 | 1987 | 35 | 0.020 |
Why?
|
| Glutathione Disulfide | 1 | 2007 | 6 | 0.020 |
Why?
|
| Glutamate-Cysteine Ligase | 1 | 2007 | 6 | 0.020 |
Why?
|
| Cesium | 3 | 1971 | 16 | 0.020 |
Why?
|
| Acetates | 2 | 1984 | 57 | 0.020 |
Why?
|
| Mice, Inbred ICR | 1 | 2007 | 75 | 0.020 |
Why?
|
| Methods | 2 | 1976 | 135 | 0.020 |
Why?
|
| gamma-Globulins | 1 | 1966 | 15 | 0.020 |
Why?
|
| Mitochondrial Membranes | 1 | 2006 | 20 | 0.020 |
Why?
|
| Proteasome Inhibitors | 1 | 2007 | 52 | 0.020 |
Why?
|
| Picornaviridae | 1 | 1966 | 4 | 0.020 |
Why?
|
| Glutathione | 1 | 2007 | 104 | 0.020 |
Why?
|
| Pituitary Gland, Anterior | 1 | 1986 | 20 | 0.020 |
Why?
|
| Oxidoreductases | 1 | 2007 | 111 | 0.020 |
Why?
|
| Nitric Oxide Synthase | 1 | 2007 | 123 | 0.020 |
Why?
|
| Fetus | 2 | 2001 | 234 | 0.020 |
Why?
|
| Carbon Isotopes | 3 | 1971 | 58 | 0.020 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2007 | 51 | 0.020 |
Why?
|
| Prolactin | 1 | 1986 | 89 | 0.020 |
Why?
|
| Crystallography, X-Ray | 1 | 2008 | 520 | 0.020 |
Why?
|
| Feeding Behavior | 1 | 2009 | 337 | 0.020 |
Why?
|
| Antibody Formation | 1 | 1987 | 169 | 0.010 |
Why?
|
| Ribosomes | 2 | 1973 | 102 | 0.010 |
Why?
|
| Alkaline Phosphatase | 3 | 1986 | 128 | 0.010 |
Why?
|
| Culture Media | 4 | 1990 | 138 | 0.010 |
Why?
|
| Nucleic Acid Denaturation | 2 | 1976 | 26 | 0.010 |
Why?
|
| Manganese | 1 | 2006 | 55 | 0.010 |
Why?
|
| Rats, Inbred Lew | 1 | 2006 | 214 | 0.010 |
Why?
|
| Imidazoles | 2 | 1998 | 138 | 0.010 |
Why?
|
| Oxidation-Reduction | 1 | 2007 | 410 | 0.010 |
Why?
|
| Microsomes | 2 | 1980 | 32 | 0.010 |
Why?
|
| Aging | 1 | 2010 | 725 | 0.010 |
Why?
|
| Sepharose | 1 | 1965 | 13 | 0.010 |
Why?
|
| Organelles | 1 | 2006 | 55 | 0.010 |
Why?
|
| Fluoresceins | 3 | 1991 | 43 | 0.010 |
Why?
|
| Testis | 1 | 1985 | 147 | 0.010 |
Why?
|
| Chondroitinases and Chondroitin Lyases | 1 | 1985 | 4 | 0.010 |
Why?
|
| Ribonuclease T1 | 2 | 1982 | 7 | 0.010 |
Why?
|
| Chemistry | 1 | 1985 | 46 | 0.010 |
Why?
|
| Somatomedins | 1 | 1985 | 28 | 0.010 |
Why?
|
| Chemical Phenomena | 1 | 1985 | 65 | 0.010 |
Why?
|
| Metaphase | 1 | 1985 | 20 | 0.010 |
Why?
|
| Movement | 1 | 1987 | 307 | 0.010 |
Why?
|
| Heparin | 1 | 1985 | 177 | 0.010 |
Why?
|
| Biosensing Techniques | 1 | 2006 | 81 | 0.010 |
Why?
|
| Semliki forest virus | 2 | 1983 | 8 | 0.010 |
Why?
|
| Cyanogen Bromide | 2 | 1981 | 7 | 0.010 |
Why?
|
| Polysaccharides | 1 | 1965 | 94 | 0.010 |
Why?
|
| Micrococcal Nuclease | 1 | 1984 | 8 | 0.010 |
Why?
|
| Hemagglutination Tests | 1 | 1964 | 9 | 0.010 |
Why?
|
| Centrifugation | 1 | 1964 | 19 | 0.010 |
Why?
|
| Erythrocyte Membrane | 1 | 1964 | 60 | 0.010 |
Why?
|
| Genotype | 2 | 2007 | 1866 | 0.010 |
Why?
|
| Indicators and Reagents | 1 | 1964 | 68 | 0.010 |
Why?
|
| Terpenes | 2 | 1994 | 18 | 0.010 |
Why?
|
| Agar | 1 | 1964 | 9 | 0.010 |
Why?
|
| Umbilical Cord | 1 | 1984 | 39 | 0.010 |
Why?
|
| Subcellular Fractions | 1 | 1984 | 83 | 0.010 |
Why?
|
| Spectrophotometry | 1 | 1964 | 102 | 0.010 |
Why?
|
| Newcastle disease virus | 1 | 1963 | 3 | 0.010 |
Why?
|
| Foot-and-Mouth Disease Virus | 1 | 1963 | 3 | 0.010 |
Why?
|
| Hyaluronic Acid | 1 | 1984 | 46 | 0.010 |
Why?
|
| Genetic Markers | 1 | 1985 | 469 | 0.010 |
Why?
|
| Peptide Chain Termination, Translational | 1 | 1983 | 5 | 0.010 |
Why?
|
| Biological Assay | 1 | 1963 | 82 | 0.010 |
Why?
|
| Proprotein Convertases | 1 | 2003 | 27 | 0.010 |
Why?
|
| Oligonucleotides | 1 | 1983 | 91 | 0.010 |
Why?
|
| Genomic Library | 2 | 1993 | 30 | 0.010 |
Why?
|
| Interferons | 1 | 1963 | 112 | 0.010 |
Why?
|
| Rabbits | 3 | 1990 | 579 | 0.010 |
Why?
|
| Alpharetrovirus | 1 | 1983 | 1 | 0.010 |
Why?
|
| Pharmacology | 1 | 1963 | 11 | 0.010 |
Why?
|
| Thermodynamics | 1 | 2004 | 324 | 0.010 |
Why?
|
| Sequence Deletion | 2 | 1994 | 206 | 0.010 |
Why?
|
| Dimercaprol | 1 | 1963 | 7 | 0.010 |
Why?
|
| Herpesviridae | 1 | 1963 | 13 | 0.010 |
Why?
|
| Polyethylene Glycols | 2 | 1976 | 371 | 0.010 |
Why?
|
| DNA, Single-Stranded | 2 | 1981 | 95 | 0.010 |
Why?
|
| Salts | 1 | 1963 | 18 | 0.010 |
Why?
|
| Neuraminidase | 1 | 1963 | 44 | 0.010 |
Why?
|
| Cell Biology | 1 | 1963 | 15 | 0.010 |
Why?
|
| Catalytic Domain | 1 | 2003 | 162 | 0.010 |
Why?
|
| Histocompatibility Antigens | 1 | 1982 | 37 | 0.010 |
Why?
|
| Deoxyribonuclease EcoRI | 1 | 1982 | 6 | 0.010 |
Why?
|
| Receptors, Vitronectin | 1 | 2002 | 5 | 0.010 |
Why?
|
| Ribonuclease, Pancreatic | 1 | 1982 | 24 | 0.010 |
Why?
|
| Viruses | 1 | 1963 | 64 | 0.010 |
Why?
|
| RNA, Neoplasm | 1 | 1982 | 86 | 0.010 |
Why?
|
| Influenza A virus | 1 | 1963 | 172 | 0.010 |
Why?
|
| Integrins | 1 | 2002 | 79 | 0.010 |
Why?
|
| Electrophoresis, Disc | 2 | 1971 | 13 | 0.010 |
Why?
|
| Hot Temperature | 2 | 1996 | 217 | 0.010 |
Why?
|
| Single-Strand Specific DNA and RNA Endonucleases | 1 | 1981 | 5 | 0.010 |
Why?
|
| Vertebrates | 1 | 1963 | 112 | 0.010 |
Why?
|
| Exons | 2 | 1994 | 447 | 0.010 |
Why?
|
| Ultraviolet Rays | 2 | 1982 | 192 | 0.010 |
Why?
|
| Computers | 1 | 1981 | 102 | 0.010 |
Why?
|
| Gene Transfer, Horizontal | 1 | 2001 | 41 | 0.010 |
Why?
|
| Methionine | 1 | 1981 | 64 | 0.010 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2001 | 123 | 0.010 |
Why?
|
| omega-Agatoxin IVA | 1 | 2000 | 2 | 0.010 |
Why?
|
| omega-Conotoxin GVIA | 1 | 2000 | 8 | 0.010 |
Why?
|
| Nimodipine | 1 | 2000 | 12 | 0.010 |
Why?
|
| Spider Venoms | 1 | 2000 | 10 | 0.010 |
Why?
|
| Barium | 1 | 2000 | 32 | 0.010 |
Why?
|
| Cell Extracts | 1 | 2000 | 14 | 0.010 |
Why?
|
| Triiodothyronine | 1 | 1982 | 361 | 0.010 |
Why?
|
| Ion Transport | 1 | 2000 | 82 | 0.010 |
Why?
|
| Transcriptional Activation | 1 | 2001 | 290 | 0.010 |
Why?
|
| Sucrose | 2 | 1971 | 63 | 0.010 |
Why?
|
| Open Reading Frames | 1 | 2000 | 113 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 2 | 2002 | 1385 | 0.010 |
Why?
|
| Chondroitin | 1 | 1980 | 2 | 0.010 |
Why?
|
| Tunicamycin | 1 | 1980 | 10 | 0.010 |
Why?
|
| Xylose | 1 | 1980 | 9 | 0.010 |
Why?
|
| Antigen-Antibody Reactions | 1 | 1960 | 18 | 0.010 |
Why?
|
| Serine Endopeptidases | 1 | 1980 | 148 | 0.010 |
Why?
|
| Dichlororibofuranosylbenzimidazole | 1 | 1979 | 4 | 0.010 |
Why?
|
| bcl-X Protein | 1 | 2000 | 54 | 0.010 |
Why?
|
| Radioimmunoassay | 1 | 1980 | 139 | 0.010 |
Why?
|
| Chondrosarcoma | 1 | 1980 | 41 | 0.010 |
Why?
|
| Immune Sera | 2 | 1986 | 48 | 0.010 |
Why?
|
| Plant Viruses | 2 | 1972 | 4 | 0.010 |
Why?
|
| Synaptic Transmission | 1 | 2000 | 223 | 0.010 |
Why?
|
| Listeriosis | 1 | 1960 | 90 | 0.010 |
Why?
|
| Cerebellum | 1 | 2000 | 247 | 0.010 |
Why?
|
| Neoplasm Proteins | 1 | 1982 | 537 | 0.010 |
Why?
|
| Glyceraldehyde | 1 | 1998 | 4 | 0.010 |
Why?
|
| Antigens, Surface | 1 | 1978 | 97 | 0.010 |
Why?
|
| Transplantation Immunology | 1 | 1978 | 83 | 0.010 |
Why?
|
| Intracellular Fluid | 1 | 1998 | 32 | 0.010 |
Why?
|
| Sarcoplasmic Reticulum | 1 | 1998 | 24 | 0.010 |
Why?
|
| Peptide YY | 1 | 1998 | 9 | 0.010 |
Why?
|
| Centrifugation, Zonal | 2 | 1975 | 5 | 0.010 |
Why?
|
| Genetic Complementation Test | 1 | 1978 | 84 | 0.010 |
Why?
|
| Electric Conductivity | 1 | 1998 | 142 | 0.010 |
Why?
|
| Receptors, CCR10 | 1 | 1997 | 1 | 0.010 |
Why?
|
| Chemokine CCL7 | 1 | 1997 | 2 | 0.010 |
Why?
|
| Chemokine CCL5 | 1 | 1997 | 15 | 0.010 |
Why?
|
| Virion | 1 | 1978 | 61 | 0.010 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 1984 | 1073 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 1997 | 54 | 0.010 |
Why?
|
| Binding, Competitive | 1 | 1997 | 136 | 0.010 |
Why?
|
| Methotrexate | 1 | 1998 | 226 | 0.010 |
Why?
|
| COS Cells | 1 | 1997 | 163 | 0.010 |
Why?
|
| Coliphages | 1 | 1977 | 38 | 0.010 |
Why?
|
| Electrophoresis | 3 | 1971 | 45 | 0.010 |
Why?
|
| Organ Specificity | 1 | 1997 | 279 | 0.010 |
Why?
|
| Isotope Labeling | 2 | 1973 | 51 | 0.010 |
Why?
|
| Chromosome Deletion | 1 | 1977 | 213 | 0.010 |
Why?
|
| Polynucleotides | 2 | 1973 | 8 | 0.010 |
Why?
|
| Somatostatin | 1 | 1996 | 58 | 0.010 |
Why?
|
| Reticulocytes | 2 | 1990 | 25 | 0.010 |
Why?
|
| Cell Fractionation | 2 | 1973 | 64 | 0.010 |
Why?
|
| 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester | 1 | 1996 | 13 | 0.010 |
Why?
|
| Depression, Chemical | 2 | 1982 | 25 | 0.010 |
Why?
|
| Biological Availability | 1 | 1996 | 85 | 0.010 |
Why?
|
| Insulin-Like Growth Factor I | 2 | 1987 | 116 | 0.010 |
Why?
|
| Isometric Contraction | 1 | 1996 | 34 | 0.010 |
Why?
|
| Chromatography, Affinity | 2 | 1973 | 73 | 0.010 |
Why?
|
| Lasers | 1 | 1996 | 99 | 0.010 |
Why?
|
| Osmolar Concentration | 1 | 1996 | 166 | 0.010 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoproteins | 2 | 1988 | 21 | 0.010 |
Why?
|
| Models, Structural | 1 | 1975 | 51 | 0.010 |
Why?
|
| Kv1.5 Potassium Channel | 1 | 1995 | 10 | 0.010 |
Why?
|
| Nerve Block | 1 | 1996 | 51 | 0.010 |
Why?
|
| Tyrosine | 1 | 1975 | 131 | 0.010 |
Why?
|
| Deoxyadenosines | 2 | 1973 | 23 | 0.010 |
Why?
|
| Carcinoma, Ehrlich Tumor | 1 | 1975 | 7 | 0.010 |
Why?
|
| Nucleic Acid Renaturation | 1 | 1974 | 5 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 1998 | 638 | 0.010 |
Why?
|
| Phosphorus Radioisotopes | 1 | 1974 | 20 | 0.010 |
Why?
|
| Muscle Contraction | 1 | 1996 | 255 | 0.010 |
Why?
|
| Triticum | 1 | 1975 | 24 | 0.010 |
Why?
|
| Immunoassay | 1 | 1975 | 99 | 0.010 |
Why?
|
| Adenosine | 3 | 1972 | 274 | 0.010 |
Why?
|
| Glyceraldehyde 3-Phosphate | 1 | 1994 | 1 | 0.010 |
Why?
|
| Fura-2 | 1 | 1994 | 21 | 0.010 |
Why?
|
| Resting Phase, Cell Cycle | 1 | 1994 | 5 | 0.010 |
Why?
|
| Pain Measurement | 1 | 1996 | 373 | 0.010 |
Why?
|
| Cell Communication | 1 | 1995 | 217 | 0.010 |
Why?
|
| Liposarcoma, Myxoid | 1 | 1994 | 3 | 0.010 |
Why?
|
| Calmodulin | 1 | 1994 | 50 | 0.010 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 1995 | 232 | 0.010 |
Why?
|
| Leucine Zippers | 1 | 1994 | 11 | 0.010 |
Why?
|
| Transcription Factor CHOP | 1 | 1994 | 16 | 0.010 |
Why?
|
| Lod Score | 1 | 1994 | 152 | 0.010 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 1994 | 55 | 0.010 |
Why?
|
| Bromodeoxyuridine | 1 | 1994 | 53 | 0.010 |
Why?
|
| Mice, Mutant Strains | 1 | 1994 | 217 | 0.010 |
Why?
|
| Niacinamide | 1 | 1994 | 101 | 0.010 |
Why?
|
| TATA Box | 1 | 1993 | 9 | 0.010 |
Why?
|
| Chromatography, DEAE-Cellulose | 1 | 1973 | 18 | 0.010 |
Why?
|
| Viral Plaque Assay | 1 | 1973 | 17 | 0.010 |
Why?
|
| Biophysical Phenomena | 1 | 1994 | 124 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 1994 | 287 | 0.010 |
Why?
|
| Deoxyribonucleases | 2 | 1973 | 27 | 0.010 |
Why?
|
| Staphylococcus | 1 | 1973 | 24 | 0.010 |
Why?
|
| Anesthesia | 1 | 1996 | 173 | 0.010 |
Why?
|
| Cytosol | 1 | 1994 | 192 | 0.010 |
Why?
|
| Oncogene Proteins | 1 | 1994 | 65 | 0.010 |
Why?
|
| Bacteriophage lambda | 2 | 1983 | 22 | 0.010 |
Why?
|
| Codon | 2 | 1984 | 116 | 0.010 |
Why?
|
| Nucleic Acid Heteroduplexes | 2 | 1983 | 11 | 0.010 |
Why?
|
| Amanitins | 3 | 1978 | 3 | 0.010 |
Why?
|
| Peptide Hydrolases | 1 | 1973 | 99 | 0.010 |
Why?
|
| Molecular Structure | 1 | 1994 | 305 | 0.010 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 1994 | 360 | 0.010 |
Why?
|
| Poly U | 1 | 1972 | 4 | 0.010 |
Why?
|
| Genetics, Microbial | 1 | 1972 | 9 | 0.010 |
Why?
|
| Plant Extracts | 1 | 1975 | 247 | 0.010 |
Why?
|
| Autoradiography | 2 | 1988 | 50 | 0.010 |
Why?
|
| Leukemia, Experimental | 1 | 1992 | 15 | 0.010 |
Why?
|
| Yeasts | 1 | 1972 | 50 | 0.010 |
Why?
|
| Ligases | 1 | 1972 | 44 | 0.010 |
Why?
|
| Acylation | 1 | 1972 | 68 | 0.010 |
Why?
|
| Oligoribonucleotides | 2 | 1982 | 27 | 0.010 |
Why?
|
| Embryo, Mammalian | 1 | 1992 | 217 | 0.010 |
Why?
|
| Complement Fixation Tests | 1 | 1971 | 3 | 0.010 |
Why?
|
| Magnesium | 1 | 1972 | 170 | 0.010 |
Why?
|
| Chromatography, Thin Layer | 1 | 1971 | 31 | 0.010 |
Why?
|
| DNA Damage | 1 | 1994 | 389 | 0.010 |
Why?
|
| Arginase | 1 | 1971 | 15 | 0.010 |
Why?
|
| Tartrates | 1 | 1971 | 5 | 0.010 |
Why?
|
| Buffers | 1 | 1971 | 24 | 0.010 |
Why?
|
| Acrylamides | 1 | 1971 | 34 | 0.010 |
Why?
|
| Valine | 1 | 1971 | 46 | 0.010 |
Why?
|
| RNA Polymerase II | 2 | 1982 | 60 | 0.010 |
Why?
|
| Phosphates | 1 | 1971 | 161 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 1991 | 241 | 0.010 |
Why?
|
| Quinone Reductases | 1 | 1990 | 2 | 0.010 |
Why?
|
| NAD(P)H Dehydrogenase (Quinone) | 1 | 1990 | 10 | 0.010 |
Why?
|
| Automation | 1 | 1991 | 106 | 0.000 |
Why?
|
| Suppression, Genetic | 1 | 1990 | 30 | 0.000 |
Why?
|
| Genes, ras | 1 | 1990 | 97 | 0.000 |
Why?
|
| Drosophila | 1 | 1994 | 539 | 0.000 |
Why?
|
| Micromanipulation | 1 | 1988 | 6 | 0.000 |
Why?
|
| Autolysis | 1 | 1968 | 1 | 0.000 |
Why?
|
| Microcomputers | 1 | 1988 | 24 | 0.000 |
Why?
|
| Thymidine | 1 | 1968 | 58 | 0.000 |
Why?
|
| Diploidy | 1 | 1968 | 34 | 0.000 |
Why?
|
| Signal Recognition Particle | 1 | 1988 | 13 | 0.000 |
Why?
|
| RNA Polymerase III | 2 | 1978 | 7 | 0.000 |
Why?
|
| Staining and Labeling | 1 | 1988 | 155 | 0.000 |
Why?
|
| Benzimidazoles | 1 | 1988 | 112 | 0.000 |
Why?
|
| T-Lymphocytes | 2 | 1988 | 1276 | 0.000 |
Why?
|
| RNA Precursors | 1 | 1988 | 73 | 0.000 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 1 | 1986 | 26 | 0.000 |
Why?
|
| Immunoelectrophoresis | 1 | 1966 | 12 | 0.000 |
Why?
|
| Glycols | 1 | 1966 | 8 | 0.000 |
Why?
|
| Polyethylenes | 1 | 1966 | 5 | 0.000 |
Why?
|
| Hemagglutination Inhibition Tests | 1 | 1966 | 42 | 0.000 |
Why?
|
| beta-Galactosidase | 1 | 1986 | 65 | 0.000 |
Why?
|
| Acetyltransferases | 1 | 1986 | 36 | 0.000 |
Why?
|
| Cross Reactions | 1 | 1986 | 110 | 0.000 |
Why?
|
| Antigen-Antibody Complex | 1 | 1986 | 88 | 0.000 |
Why?
|
| DNA-Directed RNA Polymerases | 2 | 1978 | 98 | 0.000 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 1988 | 416 | 0.000 |
Why?
|
| Penicillin Resistance | 1 | 1983 | 1 | 0.000 |
Why?
|
| Ampicillin | 1 | 1983 | 15 | 0.000 |
Why?
|
| Antiviral Agents | 1 | 1966 | 364 | 0.000 |
Why?
|
| Deoxyribonucleotides | 1 | 1983 | 8 | 0.000 |
Why?
|
| Quail | 1 | 1983 | 8 | 0.000 |
Why?
|
| Bacillus subtilis | 1 | 1983 | 89 | 0.000 |
Why?
|
| Countercurrent Distribution | 1 | 1962 | 2 | 0.000 |
Why?
|
| Poliomyelitis | 1 | 1962 | 12 | 0.000 |
Why?
|
| Leucine | 1 | 1982 | 56 | 0.000 |
Why?
|
| Dactinomycin | 2 | 1973 | 32 | 0.000 |
Why?
|
| H-2 Antigens | 1 | 1982 | 57 | 0.000 |
Why?
|
| RNA Polymerase I | 1 | 1982 | 7 | 0.000 |
Why?
|
| Immunoglobulin Heavy Chains | 1 | 1982 | 106 | 0.000 |
Why?
|
| Liver Neoplasms | 1 | 1988 | 773 | 0.000 |
Why?
|
| Receptors, Antigen, B-Cell | 1 | 1982 | 103 | 0.000 |
Why?
|
| Adenine | 2 | 1972 | 90 | 0.000 |
Why?
|
| Lung | 1 | 1968 | 1359 | 0.000 |
Why?
|
| Chick Embryo | 1 | 1980 | 174 | 0.000 |
Why?
|
| Endopeptidases | 1 | 1980 | 114 | 0.000 |
Why?
|
| Fluorides | 1 | 1980 | 11 | 0.000 |
Why?
|
| Carbohydrates | 1 | 1980 | 40 | 0.000 |
Why?
|
| Precipitin Tests | 1 | 1978 | 101 | 0.000 |
Why?
|
| Neoplasms, Experimental | 1 | 1980 | 259 | 0.000 |
Why?
|
| Guanosine Pentaphosphate | 1 | 1978 | 2 | 0.000 |
Why?
|
| HLA Antigens | 1 | 1978 | 228 | 0.000 |
Why?
|
| Guanosine Triphosphate | 1 | 1976 | 36 | 0.000 |
Why?
|
| Biological Evolution | 1 | 1983 | 1019 | 0.000 |
Why?
|
| Electrophoresis, Paper | 1 | 1974 | 2 | 0.000 |
Why?
|
| Chromatography, Ion Exchange | 1 | 1974 | 30 | 0.000 |
Why?
|
| Threonine | 1 | 1974 | 31 | 0.000 |
Why?
|
| RNA, Transfer | 1 | 1976 | 168 | 0.000 |
Why?
|
| Nitrosoguanidines | 1 | 1973 | 2 | 0.000 |
Why?
|
| Alkanesulfonates | 1 | 1973 | 3 | 0.000 |
Why?
|
| Proline | 1 | 1974 | 49 | 0.000 |
Why?
|
| Caseins | 1 | 1973 | 9 | 0.000 |
Why?
|
| Carbohydrate Metabolism | 1 | 1973 | 30 | 0.000 |
Why?
|
| Mutagens | 1 | 1973 | 29 | 0.000 |
Why?
|
| Galactose | 1 | 1973 | 27 | 0.000 |
Why?
|
| Alanine | 1 | 1974 | 82 | 0.000 |
Why?
|
| Acetylation | 1 | 1974 | 149 | 0.000 |
Why?
|
| Coagulase | 1 | 1973 | 29 | 0.000 |
Why?
|
| Milk | 1 | 1973 | 56 | 0.000 |
Why?
|
| Serine | 1 | 1974 | 102 | 0.000 |
Why?
|
| Ultrafiltration | 1 | 1973 | 11 | 0.000 |
Why?
|
| Mass Spectrometry | 1 | 1974 | 187 | 0.000 |
Why?
|
| Polyribosomes | 1 | 1972 | 20 | 0.000 |
Why?
|
| Cycloheximide | 1 | 1972 | 54 | 0.000 |
Why?
|
| Dimethyl Sulfoxide | 1 | 1972 | 40 | 0.000 |
Why?
|
| Furans | 1 | 1971 | 19 | 0.000 |
Why?
|
| Methanol | 1 | 1971 | 11 | 0.000 |
Why?
|
| X-Ray Diffraction | 1 | 1965 | 131 | 0.000 |
Why?
|
| Crystallization | 1 | 1965 | 215 | 0.000 |
Why?
|